Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
111
datasets available to search
ShareScore release 0.9.0
Dataset results
111 results for “IMC”
A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer
ClinicalTrials.gov study NCT00862784. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of IMC-EB10 in Participant With Leukemia
ClinicalTrials.gov study NCT00887926. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer
ClinicalTrials.gov study NCT00520481. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of IMC-11F8 in Participants With Colorectal Cancer
ClinicalTrials.gov study NCT00835185. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
ClinicalTrials.gov study NCT00627042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Olaratumab (IMC-3G3) in Prostate Cancer
ClinicalTrials.gov study NCT01204710. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00735696. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
ClinicalTrials.gov study NCT04414163. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage
ClinicalTrials.gov study NCT00887159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
ClinicalTrials.gov study NCT01286818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
ClinicalTrials.gov study NCT01606748. IPD Sharing: YES. Countries: 1. Publications: 0.
An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma
ClinicalTrials.gov study NCT01137006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver
ClinicalTrials.gov study NCT00906373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00918203. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
ClinicalTrials.gov study NCT01182883. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00986674. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IMC-A12 in Treating Patients With Advanced Liver Cancer
ClinicalTrials.gov study NCT00639509. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors
ClinicalTrials.gov study NCT01199822. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preoperative Treatment With Cetuximab and/or IMC-A12
ClinicalTrials.gov study NCT00957853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT00895180. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.